Search Within

Vicky Makker

Formats
  1. Meeting Abstract (144)
  2. Journal Article (111)
  3. Review (9)
  4. Editorial (3)
  5. Book Section (2)
  6. Guidelines (1)
Groups
  1. Department of Medicine (270)
  2. GDMT, Medicine (270)
  3. Gynecologic Medicine Service (270)
  4. Gynecology Disease Management Team (270)
  5. Solid Tumor Oncology Division (270)
  6. Surgery (94)

More Groups

People
  1. Carol Aghajanian (91)
  2. Nadeem Abu-Rustum (77)
  3. Mario Leitao (49)
  4. Alexia Iasonos (47)
  5. Kaled Alektiar (45)
  6. Qin Zhou (43)

More People

Years
  1. 2025 (14)
  2. 2024 (35)
  3. 2023 (39)
  4. 2022 (36)
  5. 2021 (19)
  6. 2020 (26)

More Years

Publications
  1. Gynecologic Oncology (65)
  2. Journal of Clinical Oncology (58)
  3. International Journal of Gynecological Cancer (38)
  4. Annals of Oncology (23)
  5. Gynecologic Oncology Reports (8)
  6. Clinical Cancer Research (6)

More Publications

Publishers
  1. Elsevier B.V. (73)
  2. American Society of Clinical Oncology (61)
  3. Lippincott Williams & Wilkins (39)
  4. Oxford University Press (26)
  5. American Association for Cancer Research (13)
  6. Elsevier Inc. (9)

More Publishers

Results (270)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Keynote-C93/GOG-3064/ENGOT-EN15: Phase 3, randomized, open-label study of first-line pembrolizumab versus platinum-doublet chemotherapy in mismatch repair deficient advanced or recurrent endometrial carcinoma
    Meeting Abstract

    Slomovitz, B.; Cibula, D.; Gultekin, M.; Mirza, M.; Maćkowiak-Matejczyk, B.; Taylor, A.; Romero, I.; Colombo, N.; Korach, J.; Zhu, J.; more...
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Real-world experience and common adverse events when using combination lenvatinib and pembrolizumab for the treatment of recurrent uterine cancer
    Meeting Abstract

    Zammarrelli, W.; Espino, K.; Yeoshoua, E.; Ehmann, S.; Rubinstein, M.; Green, A.; Makker, V.
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Updated safety of lenvatinib + pembrolizumab vs treatment of physician's choice in patients with advanced endometrial cancer: Study 309/KEYNOTE-775
    Meeting Abstract

    Makker, V.; Colombo, N.; Casado Herráez, A.; Monk, B.; Mackay, H.; Santin, A.; Miller, D.; Moore, R.; Ray-Coquard, I.; Shapira-Frommer, R.; more...
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Germline pathogenic variants in DNA repair genes and endometrial cancer risk
    Meeting Abstract

    Gordhandas, S.; Rios-Doria, E.; Cadoo, K.; Catchings, A.; Maio, A.; Kemel, Y.; Manning-Geist, B.; Sia, T.; Roche, K. L.; Leitao, M.; more...
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Lenvatinib plus pembrolizumab versus treatment of physician's choice in patients with previously treated advanced endometrial cancer: Study 309/KEYNOTE-775 Asian subgroup
    Meeting Abstract

    Yonemori, K.; Fujiwara, K.; Hasegawa, K.; Yunokawa, M.; Ushijima, K.; Suzuki, S.; Shikama, A.; Minobe, S.; Usami, T.; Kim, J. W.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Prognosis of isolated tumor cells and the utility of molecular classification in early stage endometrioid endometrial cancer
    Meeting Abstract

    Rios-Doria, E.; Abu-Rustum, N.; Alektiar, K.; Makker, V.; Liu, Y.; Zamarin, D.; Friedman, C.; Aghajanian, C.; Ellenson, L.; Weigelt, B.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Molecular classification of endometrial carcinomas: A single-institution review
    Meeting Abstract

    Rios-Doria, E.; Abu-Rustum, N.; Leitao, M.; Alektiar, K.; Makker, V.; Liu, Y.; Zamarin, D.; Friedman, C.; Aghajanian, C.; Ellenson, L.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Outcomes after recurrence of low-grade endometrial stromal sarcoma (LGESS)
    Meeting Abstract

    Miller, K.; Smith, E.; Sonoda, Y.; Mueller, J.; Alektiar, A.; Makker, V.; Hensley, M.; Abu-Rustum, N.; Leitao, M.
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • LIO-1: Initial phase 2 experience of lucitanib + nivolumab in patients with metastatic or recurrent cervical cancer (NCT04042116; ENGOT-GYN3/AGO/LIO)
    Meeting Abstract

    Oaknin, A.; Backes, F.; Van Nieuwenhuysen, E.; Eskander, R.; González-Martín, A.; Makker, V.; Marth, C.; Patel, M.; Penson, R.; Redondo, A.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Risk stratification of stage I grade 3 endometrioid endometrial carcinoma
    Meeting Abstract

    Zammarrelli, W.; Kim, S.; Paula, A. D. C.; Rios-Doria, E.; Zhou, Q.; Alektiar, K.; Aghajanian, C.; Makker, V.; Leitao, M.; Abu-Rustum, N.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save